News | June 10, 2022
GE Healthcare’s molecular imaging solutions enable precision health & theranostics for prostate cancer
Healthcare is timely and personal – and its delivery should be too
Healthcare is timely and personal – and its delivery should be too
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
Harbour BioMed brings advanced antibody discovery platforms to the table
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
Subscribe To Our Newsletter & Stay Updated
